WELL Health Technologies Corp T.WELL

Alternate Symbol(s): T.WELL.DB | WHTCF

Healthcare

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.

TSX:WELL - Post by User

WELL Health Technologies Corp > CRH Medical - Investment Thesis Overview

<< Previous

Bullboard Posts

Next >>

Comment by Aarman4on May 07, 2021 1:22pm

140 Views

Post# 33153267

RE:CRH Medical - Investment Thesis Overview

CEO Shabazi mentioned in his recent interview(I forget the name of the interviewer), about how he was influenced by the book "The Outsiders"..... I read the book about a year ago, and it is FANTASTIC... It is about CEO's and the different path's they took in order to raise shareholder value.

Our CEO is very similar to one of those CEO's in his M&A style.

We are in with a good team here folks, hold your shares long term, things are only going to get better!

Cheers!

monty613 wrote: These write-ups are dated, but give a good overview on the CRH Medical business and the investment thesis in general.

This company is the largest piece of WELL now and it is a solid roll-up/consolidator in its own right. They deploy around ~$30MM per year for acquisitions, buying at 2.5-3X revenue or 4-5X EBITDA and they generate ~40% FCF margins.

Under WELL I suspect the M&A program will accelerate. WELL will then use the free cash flow firepower CRH generates to leverage and take on more debt to buy other businesses and grow their portfolio. The Berkshire Hathaway of healthcare.

https://seekingalpha.com/article/4182956-crh-medical-cheap-high-quality-consolidator-of-gi-anesthesia-space

https://seekingalpha.com/article/4128741-crh-medical-less-6_5x-free-cash-flow-extreme-mispricing-favorable-risk-reward-scenario